FDA Issues Guidance on Payor Communications, Non-Label Information
Two final FDA guidances published Tuesday clarify which information drugmakers can provide to payors and what non-label information they can communicate.
Source: Drug Industry Daily
Two final FDA guidances published Tuesday clarify which information drugmakers can provide to payors and what non-label information they can communicate.
Source: Drug Industry Daily